Report Detail

Request for Sample of this report

Other Global Addictions Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM3843191
    • |
  • 19 August, 2024
    • |
  • Global
    • |
  • 104 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global Addictions Therapeutics market size was valued at USD 4883 million in 2023 and is forecast to a readjusted size of USD 6471.5 million by 2030 with a CAGR of 4.1% during review period.
Addiction is a brain disorder characterized by compulsive engagement in rewarding stimuli despite adverse consequences.Despite the involvement of a number of psychosocial factors, a biological process – one which is induced by repeated exposure to an addictive stimulus – is the core pathology that drives the development and maintenance of an addiction.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Addictions Therapeutics industry chain, the market status of Public (Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics), Private (Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Addictions Therapeutics.
Regionally, the report analyzes the Addictions Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Addictions Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Addictions Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Addictions Therapeutics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Alcohol Addiction Therapeutics, Tobacco Addiction Therapeutics).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Addictions Therapeutics market.
Regional Analysis: The report involves examining the Addictions Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Addictions Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Addictions Therapeutics:
Company Analysis: Report covers individual Addictions Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Addictions Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Public, Private).
Technology Analysis: Report covers specific technologies relevant to Addictions Therapeutics. It assesses the current state, advancements, and potential future developments in Addictions Therapeutics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Addictions Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Addictions Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Alcohol Addiction Therapeutics
Tobacco Addiction Therapeutics
Drug Addiction Therapeutics
Market segment by Application
Public
Private
Government
Market segment by players, this report covers
Alkermes Plc
Amneal Pharmaceuticals Inc.
Indivior Plc
Johnson & Johnson Services Inc.
Mylan NV
Novartis AG
Novo Nordisk AS
Opiant Pharmaceuticals Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Addictions Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Addictions Therapeutics, with revenue, gross margin and global market share of Addictions Therapeutics from 2019 to 2024.
Chapter 3, the Addictions Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Addictions Therapeutics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Addictions Therapeutics.
Chapter 13, to describe Addictions Therapeutics research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Addictions Therapeutics
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Addictions Therapeutics by Type
    • 1.3.1 Overview: Global Addictions Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Addictions Therapeutics Consumption Value Market Share by Type in 2023
    • 1.3.3 Alcohol Addiction Therapeutics
    • 1.3.4 Tobacco Addiction Therapeutics
    • 1.3.5 Drug Addiction Therapeutics
  • 1.4 Global Addictions Therapeutics Market by Application
    • 1.4.1 Overview: Global Addictions Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Public
    • 1.4.3 Private
    • 1.4.4 Government
  • 1.5 Global Addictions Therapeutics Market Size & Forecast
  • 1.6 Global Addictions Therapeutics Market Size and Forecast by Region
    • 1.6.1 Global Addictions Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Addictions Therapeutics Market Size by Region, (2019-2030)
    • 1.6.3 North America Addictions Therapeutics Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Addictions Therapeutics Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Addictions Therapeutics Market Size and Prospect (2019-2030)
    • 1.6.6 South America Addictions Therapeutics Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Addictions Therapeutics Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Alkermes Plc
    • 2.1.1 Alkermes Plc Details
    • 2.1.2 Alkermes Plc Major Business
    • 2.1.3 Alkermes Plc Addictions Therapeutics Product and Solutions
    • 2.1.4 Alkermes Plc Addictions Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Alkermes Plc Recent Developments and Future Plans
  • 2.2 Amneal Pharmaceuticals Inc.
    • 2.2.1 Amneal Pharmaceuticals Inc. Details
    • 2.2.2 Amneal Pharmaceuticals Inc. Major Business
    • 2.2.3 Amneal Pharmaceuticals Inc. Addictions Therapeutics Product and Solutions
    • 2.2.4 Amneal Pharmaceuticals Inc. Addictions Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Amneal Pharmaceuticals Inc. Recent Developments and Future Plans
  • 2.3 Indivior Plc
    • 2.3.1 Indivior Plc Details
    • 2.3.2 Indivior Plc Major Business
    • 2.3.3 Indivior Plc Addictions Therapeutics Product and Solutions
    • 2.3.4 Indivior Plc Addictions Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Indivior Plc Recent Developments and Future Plans
  • 2.4 Johnson & Johnson Services Inc.
    • 2.4.1 Johnson & Johnson Services Inc. Details
    • 2.4.2 Johnson & Johnson Services Inc. Major Business
    • 2.4.3 Johnson & Johnson Services Inc. Addictions Therapeutics Product and Solutions
    • 2.4.4 Johnson & Johnson Services Inc. Addictions Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Johnson & Johnson Services Inc. Recent Developments and Future Plans
  • 2.5 Mylan NV
    • 2.5.1 Mylan NV Details
    • 2.5.2 Mylan NV Major Business
    • 2.5.3 Mylan NV Addictions Therapeutics Product and Solutions
    • 2.5.4 Mylan NV Addictions Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Mylan NV Recent Developments and Future Plans
  • 2.6 Novartis AG
    • 2.6.1 Novartis AG Details
    • 2.6.2 Novartis AG Major Business
    • 2.6.3 Novartis AG Addictions Therapeutics Product and Solutions
    • 2.6.4 Novartis AG Addictions Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Novartis AG Recent Developments and Future Plans
  • 2.7 Novo Nordisk AS
    • 2.7.1 Novo Nordisk AS Details
    • 2.7.2 Novo Nordisk AS Major Business
    • 2.7.3 Novo Nordisk AS Addictions Therapeutics Product and Solutions
    • 2.7.4 Novo Nordisk AS Addictions Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Novo Nordisk AS Recent Developments and Future Plans
  • 2.8 Opiant Pharmaceuticals Inc.
    • 2.8.1 Opiant Pharmaceuticals Inc. Details
    • 2.8.2 Opiant Pharmaceuticals Inc. Major Business
    • 2.8.3 Opiant Pharmaceuticals Inc. Addictions Therapeutics Product and Solutions
    • 2.8.4 Opiant Pharmaceuticals Inc. Addictions Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Opiant Pharmaceuticals Inc. Recent Developments and Future Plans
  • 2.9 Pfizer Inc.
    • 2.9.1 Pfizer Inc. Details
    • 2.9.2 Pfizer Inc. Major Business
    • 2.9.3 Pfizer Inc. Addictions Therapeutics Product and Solutions
    • 2.9.4 Pfizer Inc. Addictions Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Pfizer Inc. Recent Developments and Future Plans
  • 2.10 Teva Pharmaceutical Industries Ltd.
    • 2.10.1 Teva Pharmaceutical Industries Ltd. Details
    • 2.10.2 Teva Pharmaceutical Industries Ltd. Major Business
    • 2.10.3 Teva Pharmaceutical Industries Ltd. Addictions Therapeutics Product and Solutions
    • 2.10.4 Teva Pharmaceutical Industries Ltd. Addictions Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Addictions Therapeutics Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Addictions Therapeutics by Company Revenue
    • 3.2.2 Top 3 Addictions Therapeutics Players Market Share in 2023
    • 3.2.3 Top 6 Addictions Therapeutics Players Market Share in 2023
  • 3.3 Addictions Therapeutics Market: Overall Company Footprint Analysis
    • 3.3.1 Addictions Therapeutics Market: Region Footprint
    • 3.3.2 Addictions Therapeutics Market: Company Product Type Footprint
    • 3.3.3 Addictions Therapeutics Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Addictions Therapeutics Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Addictions Therapeutics Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Addictions Therapeutics Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Addictions Therapeutics Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Addictions Therapeutics Consumption Value by Type (2019-2030)
  • 6.2 North America Addictions Therapeutics Consumption Value by Application (2019-2030)
  • 6.3 North America Addictions Therapeutics Market Size by Country
    • 6.3.1 North America Addictions Therapeutics Consumption Value by Country (2019-2030)
    • 6.3.2 United States Addictions Therapeutics Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Addictions Therapeutics Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Addictions Therapeutics Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Addictions Therapeutics Consumption Value by Type (2019-2030)
  • 7.2 Europe Addictions Therapeutics Consumption Value by Application (2019-2030)
  • 7.3 Europe Addictions Therapeutics Market Size by Country
    • 7.3.1 Europe Addictions Therapeutics Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Addictions Therapeutics Market Size and Forecast (2019-2030)
    • 7.3.3 France Addictions Therapeutics Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Addictions Therapeutics Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Addictions Therapeutics Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Addictions Therapeutics Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Addictions Therapeutics Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Addictions Therapeutics Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Addictions Therapeutics Market Size by Region
    • 8.3.1 Asia-Pacific Addictions Therapeutics Consumption Value by Region (2019-2030)
    • 8.3.2 China Addictions Therapeutics Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Addictions Therapeutics Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Addictions Therapeutics Market Size and Forecast (2019-2030)
    • 8.3.5 India Addictions Therapeutics Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Addictions Therapeutics Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Addictions Therapeutics Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Addictions Therapeutics Consumption Value by Type (2019-2030)
  • 9.2 South America Addictions Therapeutics Consumption Value by Application (2019-2030)
  • 9.3 South America Addictions Therapeutics Market Size by Country
    • 9.3.1 South America Addictions Therapeutics Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Addictions Therapeutics Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Addictions Therapeutics Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Addictions Therapeutics Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Addictions Therapeutics Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Addictions Therapeutics Market Size by Country
    • 10.3.1 Middle East & Africa Addictions Therapeutics Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Addictions Therapeutics Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Addictions Therapeutics Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Addictions Therapeutics Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Addictions Therapeutics Market Drivers
  • 11.2 Addictions Therapeutics Market Restraints
  • 11.3 Addictions Therapeutics Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Addictions Therapeutics Industry Chain
  • 12.2 Addictions Therapeutics Upstream Analysis
  • 12.3 Addictions Therapeutics Midstream Analysis
  • 12.4 Addictions Therapeutics Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Addictions Therapeutics. Industry analysis & Market Report on Addictions Therapeutics is a syndicated market report, published as Global Addictions Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Addictions Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,686.56
    		4,029.84
    		5,373.12
    		3,201.60
    		4,802.40
    		6,403.20
    		530,108.40
    		795,162.60
    		1,060,216.80
    		292,772.40
    		439,158.60
    		585,544.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo